Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
Public ClinicalTrials.gov record NCT02294058. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Double-Dummy, Active Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of RPC1063 Administered Orally To Relapsing Multiple Sclerosis Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).
Study identification
- NCT ID
- NCT02294058
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,346 participants
Conditions and interventions
Conditions
Interventions
- Ozanimod Drug
- Interferon beta-1a Drug
- Placebo to ozanimod Drug
- Placebo to interferon beta-1a Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2014 (Actual)
- Primary completion
- Dec 22, 2016 (Actual)
- Completion
- Dec 22, 2016 (Actual)
- Last update posted
- Nov 25, 2020
2014 – 2016
United States locations
- U.S. sites
- 40
- U.S. states
- 22
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Xenosciences Inc | Phoenix | Arizona | 85004 | — |
| St Josephs Hospital and Medical Center | Phoenix | Arizona | 85013 | — |
| Northwest Neuro Specialists PLLC | Tucson | Arizona | 85712 | — |
| Alta Bates Summit Medical Center | Berkeley | California | 94705 | — |
| Collaborative Neuroscience Network Inc | Long Beach | California | 90806 | — |
| University of California Davis Medical Center | Sacramento | California | 95817 | — |
| Multiple Sclerosis Center at UCSF | San Francisco | California | 94158 | — |
| Denver Neurological Clinic | Denver | Colorado | 80210 | — |
| Neurology Associates PA | Maitland | Florida | 32751 | — |
| Neurology Associates of Ormond Beach | Ormond Beach | Florida | 32174 | — |
| Infinity Clinical Research LLC | Pompano Beach | Florida | 33060 | — |
| Neurostudies Inc | Port Charlotte | Florida | 33952 | — |
| Roskamp Institute | Sarasota | Florida | 34243 | — |
| Axiom Clinical Research of Florida | Tampa | Florida | 33609 | — |
| Meridien Research | Tampa | Florida | 33634 | — |
| West Georgia Sleep Disorder Center and Neurology Associates | Douglasville | Georgia | 30134 | — |
| Consultants In Neurology | Northbrook | Illinois | 60062 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| MidAmerica Neuroscience Research Foundation | Lenexa | Kansas | 66214 | — |
| Associates In Neurology | Lexington | Kentucky | 40513 | — |
| Norton Healthcare | Louisville | Kentucky | 40207 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Cleveland Clinic Lou Ruvo Center for Brain Health | Las Vegas | Nevada | 89106 | — |
| Neurology Specialists of Monmouth County PA | West Long Branch | New Jersey | 07764 | — |
| Neuro Medical Care Associates PLLC | Johnson City | New York | 13790 | — |
| Raleigh Neurology Associates PA | Raleigh | North Carolina | 27607 | — |
| Neurology and Neuroscience Associates Inc. | Akron | Ohio | 44320 | — |
| Neurological Research Institute Inc | Columbus | Ohio | 43221 | — |
| Providence Multiple Sclerosis Center | Portland | Oregon | 97225 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Hope Neurology MS Center | Knoxville | Tennessee | 37922 | — |
| University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Bhupesh Dihenia MD PA | Lubbock | Texas | 79410 | — |
| EvergreenHealth | Kirkland | Washington | 98034 | — |
| The Polyclinic | Seattle | Washington | 98104 | — |
| Neurology of Neurosurgery Associates of Tacoma | Tacoma | Washington | 98405 | — |
| Center for Neurological Disorders | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 184 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02294058, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 25, 2020 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02294058 live on ClinicalTrials.gov.